대한의생명과학회지 (Biomedical Science Letters)

  • 제26권3호
  • /
  • Pages.192-200
  • /
  • 2020
  • /
  • 1738-3226(pISSN)
  • /
  • 2288-7415(eISSN)
대한의생명과학회 (The Korean Society for Biomedical Laboratory Sciences)
권호 표지
DOI QR코드

DOI QR Code

Zanthoxylum Piperitum Attenuates the Allergic Inflammation in vivo and in vitro

  • Jeong, Duck-Ja (College of Korean Medicine, Daegu Haany University) ;
  • Kim, Su-Jin (Department of Biotechnology and Convergence, Daegu Haany University)
  • 투고 : 2020.08.20
  • 심사 : 2020.09.10
  • 발행 : 2020.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Natural products have received revived interest via traditional remedies or alternative medicine used for the treatment of various diseases. Zanthoxylum piperitum (ZP) has been utilized in traditional medicine for various medicinal purposes. The present study was conducted to evaluate whether ZP modulates allergic inflammation both in vivo and in vitro. We examined the pharmacological effects of ZP on 2, 4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis (AD) symptoms in mice. Additionally, in order to clarify the anti-inflammatory mechanisms of ZP, we elucidate the effect of ZP on the expression levels of inflammatory cytokines and nuclear factor-κB (NF-κB) in phorbol 12-myristate 13-acetate plus calcium ionophore A23187 (PMACI)-stimulated human mast cells (HMC-1). The results demonstrated that ZP attenuated AD clinical symptoms such as erythema, edema and dryness as well as histamine and IgE serum levels in DNCB-induced AD model mice. Additionally, ZP suppressed the expression of inflammatory cytokines and activation of NF-κB in AD-like skin lesions and stimulated HMC-1. These results provide experimental evidence that ZP may be useful candidate for treating allergic inflammation including AD.

키워드

참고문헌

  1. Berke R, Singh A, Guralnick M. Atopic dermatitis: an overview. American Family Physician. 2012. 86: 35-42.
  2. Birrell MA, Hardaker E, Wong S, McCluskie K, Catley M, De AJ, Newton R, Haj-Yahia S, Pun KT, Watts CJ, Shaw RJ, Savage TJ, Belvisi MG. Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma. American Journal of Respiratory and Critical Care Medicine. 2005. 172: 962-971. https://doi.org/10.1164/rccm.200412-1647OC
  3. Chan CC, Liou CJ, Xu PY, Shen JJ, Kuo ML, Len WB, Chang LE, Huang WC. Effect of dehydroepiandrosterone on atopic dermatitis-like skin lesions induced by 1-chloro-2,4-dinitrobenzene in mouse. Journal of Dermatological Science. 2013. 72: 149-157. https://doi.org/10.1016/j.jdermsci.2013.06.015
  4. Choi SI, Chang KM, Lee YS, Kim GH. Antibacterial activity of essential oils from Zanthoxylum piperitum A.P. DC. and Zanthoxylum schinifolium. Food Science and Biotechnology. 2008. 17: 195-198.
  5. Das A, Panda S. Use of Topical Corticosteroids in Dermatology: An Evidence-based Approach. Indian Journal of Dermatology. 2017. 62: 237-250.
  6. David Boothe W, Tarbox JA, Tarbox MB. Atopic Dermatitis: Pathophysiology. Advances in Experimental Medicine and Biology. 2017. 1027: 21-37. https://doi.org/10.1007/978-3-319-64804-0_3
  7. Fedenko ES, Elisyutina OG, Filimonova TM, Boldyreva MN, Burmenskaya OV, Rebrova OY, Yarilin AA, Khaitov RM. Cytokine gene expression in the skin and peripheral blood of atopic dermatitis patients and healthy individuals. Self Nonself. 2011. 2: 120-124. https://doi.org/10.4161/self.2.2.16939
  8. Furue M, Kadono T. "Inflammatory skin march" in atopic dermatitis and psoriasis. Inflammation Research. 2017. 66: 833-842. https://doi.org/10.1007/s00011-017-1065-z
  9. Furue M, Chiba T, Tsuji G, Ulzii D, Kido-Nakahara M, Nakahara T, Kadono T. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies. Allergology International. 2017. 66: 398-403. https://doi.org/10.1016/j.alit.2016.12.002
  10. Gilmore TD, Garbati MR. Inhibition of $NF-{\kappa}B$ signaling as a strategy in disease therapy. Current Topics in Microbiology and Immunology. 2011. 349: 245-263.
  11. Gomez G. Current Strategies to Inhibit High Affinity $Fc{\varepsilon}RI$-Mediated Signaling for the Treatment of Allergic Disease. Frontiers in Immunology. 2019. 10: 175-185. https://doi.org/10.3389/fimmu.2019.00175
  12. Hawiger J. Innate immunity and inflammation: a transcriptional paradigm. Immunologic Research. 2001. 23: 99-109. https://doi.org/10.1385/IR:23:2-3:099
  13. Huber MA, Denk A, Peter RU, Weber L, Kraut N, Wirth T. The IKK-2/Ikappa Balpha /NF-kappa B pathway plays a key role in the regulation of CCR3 and eotaxin-1 in fibroblasts. A critical link to dermatitis in Ikappa Balpha-deficient mice. Journal of Biological Chemistry. 2002. 277: 1268-1275. https://doi.org/10.1074/jbc.M109358200
  14. Kim SJ, Kim MC, Um JY, Hong SH. The beneficial effect of vanillic acid on ulcerative colitis. Molecules. 2010. 15: 7208-7217. https://doi.org/10.3390/molecules15107208
  15. Lee YS, Han SB, Ham HJ, Park JH, Lee JS, Hwang DY, Jung YS, Yoon DY, Hong JT. IL-$32{\gamma}$ suppressed atopic dermatitis through inhibition of miR-205 expression via inactivation of nuclear factor-kappa B. Journal of Allergy and Clinical Immunology. 2020. 146: 156-168. https://doi.org/10.1016/j.jaci.2019.12.905
  16. Lee KS, Jeong ES, Heo SH, Seo JH, Jeong DG, Choi YK. A novel model for human atopic dermatitis: application of repeated DNCB patch in BALB/c mice, in comparison with NC/Nga mice. Laboratory Animal Research. 2010. 26: 95-102. https://doi.org/10.5625/lar.2010.26.1.95
  17. Lim JM, Lee B, Min JH, Kim EY, Kim JH, Hong S, Kim JJ, Sohn Y, Jung HS. Effect of peiminine on DNCB-induced atopic dermatitis by inhibiting inflammatory cytokine expression in vivo and in vitro. International Immunopharmacology. 2018. 56: 135-142. https://doi.org/10.1016/j.intimp.2018.01.025
  18. Modena BD, Dazy K, White AA. Emerging concepts: mast cell involvement in allergic diseases. Translational Reserch. 2016. 174: 98-121. https://doi.org/10.1016/j.trsl.2016.02.011
  19. Nakamura H, Aoki M, Tamai K, Oishi M, Ogihara T, Kaneda Y, Morishita R. Prevention and regression of atopic dermatitis by ointment containing $NF-{\kappa}B$ decoy oligodeoxynucleotides in NC/Nga atopic mouse model. Gene Therapy. 2002. 9: 1221-1229. https://doi.org/10.1038/sj.gt.3301724
  20. Park HS, Jun DY, Fang Z, Woo MH, Kim YH. Antimicrobial activity of seeds of Zanthoxylum piperitum against oral pathogen Streptococcus mutants. Journal of Life Science. 2008. 18: 167-174. https://doi.org/10.5352/JLS.2008.18.2.167
  21. Shiohara T, Hayakawa J, Mizukawa Y. Animal models for atopic dermatitis: are they relevant to human disease?. Journal of Dermatological Science. 2004. 36: 1-9. https://doi.org/10.1016/j.jdermsci.2004.02.013
  22. Siraganian RP. Mast cell signal transduction from the high-affinity IgE receptor. Current opinion in immunology. 2003. 15: 639-646. https://doi.org/10.1016/j.coi.2003.09.010
  23. Trefzer U, Hofmann M, Sterry W, Asadullah K. Cytokine and anticytokine therapy in dermatology. Expert Opinion on Biological Therapy. 2003. 3: 733-743. https://doi.org/10.1517/14712598.3.5.733
  24. Waldman AR, Ahluwalia J, Udkoff J, Borok JF, Eichenfield LF. Atopic Dermatitis. Pediatrics in Review. 2018. 39: 180-193. https://doi.org/10.1542/pir.2016-0169
  25. Vatti RR, Ali F, Teuber S, Chang C, Gershwin ME. Hypersensitivity reactions to corticosteroids. Clinical Reviews in Allergy and Immunology. 2014. 47: 26-37. https://doi.org/10.1007/s12016-013-8365-z
  26. Voisin T, Chiu IM. Molecular link between itch and atopic dermatitis. Proceedings of the National Academy of Sciences of the United States of America. 2018. 115: 12851-12853. https://doi.org/10.1073/pnas.1818879115